Skip to main content

and
  1. Article

    Open Access

    Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma

    Esophageal carcinoma is a type of cancer that occurs in the esophagus. For patients with locally advanced or metastatic esophageal squamous cell carcinoma who have either experienced disease progression follow...

    **yu Chen, Chang Fu, Lin Shen, Zhengyang Fei, Mengjie Luo in BMC Health Services Research (2024)